RemeGen CEO on H.K. IPO, Strategy, Drugs in Pipeline - THEMARKETTRENDZ

Post Top Ad

Sunday, 8 November 2020

RemeGen CEO on H.K. IPO, Strategy, Drugs in Pipeline



Nov.08 -- Fang Jianmin, co-founder and chief executive officer of RemeGen Co., discusses the Chinese biotechnology company's initial public offering, strategy, and the drugs in its pipeline. RemeGen jumped more than 30 percent on its Hong Kong trading debut. Fang speaks with Juliette Saly and Rishaad Salamat on "Bloomberg Markets: Asia."
View on YouTube

No comments:

Post a comment

Post Bottom Ad